In practice, identifying thrombophilia (e.g., Factor V Leiden mutation, prothrombin mutation, protein C or S deficiency, antiphospholipid antibodies, etc.)often raises the overall risk of venous, and in some instances arterial, thrombosis. This evidence concerns the gene F2 and Rare hereditary thrombophilia.